This is a Validated Antibody Database (VAD) review about dogs CDH2, based on 20 published articles (read how Labome selects the articles), using CDH2 antibody in all methods. It is aimed to help Labome visitors find the most suited CDH2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CDH2 synonym: NCAD

Invitrogen
mouse monoclonal (CH-19)
  • western blot; mouse; loading ...; fig 1a
In order to explore how ST8SIA2-mediated polysialylation influences oligodendrocyte differentiation and schizophrenia, Invitrogen CDH2 antibody (Thermo Scientific, MA1-91128) was used in western blot on mouse samples (fig 1a). Glia (2017) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 6d
Cell Signaling Technology CDH2 antibody (Cell Signaling Technology, 4061,) was used in western blot on human samples (fig 6d). J Exp Clin Cancer Res (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 8a
Cell Signaling Technology CDH2 antibody (CST, 4061) was used in western blot on human samples (fig 8a). Aging (Albany NY) (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology CDH2 antibody (Cell Signaling Technology, 4061) was used in western blot on human samples (fig 2a). elife (2019) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 4C
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061S) was used in western blot on human samples at 1:500 (fig 4C). Oncol Lett (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:500; loading ...; fig s5b
In order to determine the impact of smooth muscle cell beta-catenin to vascular homeostasis and arterial injury, Cell Signaling Technology CDH2 antibody (Cell signaling, 4061) was used in western blot on mouse samples at 1:500 (fig s5b). Arterioscler Thromb Vasc Biol (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology CDH2 antibody (CST, 4061) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
In order to find RE1 silencing transcription factor regulates epithelial-mesenchymal transition and neuroendecrin cell stemness acquisition in hormone-refractory prostate cancer, Cell Signaling Technology CDH2 antibody (Cell signaling, 4061) was used in western blot on human samples (fig 2c). Sci Rep (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology CDH2 antibody (Cell Signaling Technology, 4061) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3a
In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples at 1:1000 (fig s3a). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology CDH2 antibody (cell signalling, 4061S) was used in western blot on human samples (fig 1e). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3D
Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 3D). Onco Targets Ther (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 7a
In order to investigate the role of growth hormone in colon cancer, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 7a). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
In order to study the contribution of CCL7-induced epithelial-mesenchymal transition signaling to the progression and metastasis of colon cancer, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 3
Cell Signaling Technology CDH2 antibody (Cell Signaling Tech, 4061) was used in western blot on human samples (fig 3). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 1d
In order to test if ZO-1-mediated diminution of polarity results in an epithelial-to-mesenchyme transition and increased metastatic potential, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on mouse samples (fig 1d). Oncogene (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 8
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology CDH2 antibody (Cell Signaling, 4061) was used in western blot on human samples (fig 8). Neuroendocrinology (2016) ncbi
MilliporeSigma
mouse monoclonal (CH-19)
  • immunohistochemistry; rat; 1:500; fig 1d
MilliporeSigma CDH2 antibody (Sigma-Aldrich, C1821) was used in immunohistochemistry on rat samples at 1:500 (fig 1d). Sci Rep (2021) ncbi
Articles Reviewed
  1. Baeza V, Cifuentes M, Martinez F, Ramírez E, Nualart F, Ferrada L, et al. IIIG9 inhibition in adult ependymal cells changes adherens junctions structure and induces cellular detachment. Sci Rep. 2021;11:18537 pubmed publisher
  2. Cheng X, Wang J, Liu C, Jiang T, Yang N, Liu D, et al. Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway. J Exp Clin Cancer Res. 2021;40:199 pubmed publisher
  3. Tian S, Peng P, Li J, Deng H, Zhan N, Zeng Z, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway. Aging (Albany NY). 2020;12:3574-3593 pubmed publisher
  4. Adams C, Htwe H, Marsh T, Wang A, Montoya M, Subbaraj L, et al. Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer. elife. 2019;8: pubmed publisher
  5. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  6. Hu X, Zhang Z, Liang Z, Xie D, Zhang T, Yu D, et al. Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma. Oncol Lett. 2017;13:686-694 pubmed publisher
  7. Riascos Bernal D, Chinnasamy P, Gross J, Almonte V, Egaña Gorroño L, Parikh D, et al. Inhibition of Smooth Muscle ?-Catenin Hinders Neointima Formation After Vascular Injury. Arterioscler Thromb Vasc Biol. 2017;37:879-888 pubmed publisher
  8. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  9. Chang Y, Lin T, Campbell M, Pan C, Lee S, Lee H, et al. REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer. Sci Rep. 2017;7:42795 pubmed publisher
  10. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  11. Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed publisher
  12. Gong F, Guo Y, Niu Y, Jin J, Zhang X, Shi X, et al. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma. Oncotarget. 2017;8:315-328 pubmed publisher
  13. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  14. Szewczyk L, Brozko N, Nagalski A, Röckle I, Werneburg S, Hildebrandt H, et al. ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons. Glia. 2017;65:34-49 pubmed publisher
  15. Hong L, Pan F, Jiang H, Zhang L, Liu Y, Cai C, et al. miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7. Onco Targets Ther. 2016;9:2639-48 pubmed publisher
  16. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
  17. Lee Y, Kim S, Song S, Hong H, Lee Y, Oh B, et al. Crosstalk between CCL7 and CCR3 promotes metastasis of colon cancer cells via ERK-JNK signaling pathways. Oncotarget. 2016;7:36842-36853 pubmed publisher
  18. Noh H, Hah Y, Ha J, Kang M, Zada S, Rha S, et al. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity. Oncotarget. 2016;7:4632-46 pubmed publisher
  19. Nagaoka K, Fujii K, Zhang H, Usuda K, Watanabe G, Ivshina M, et al. CPEB1 mediates epithelial-to-mesenchyme transition and breast cancer metastasis. Oncogene. 2016;35:2893-901 pubmed publisher
  20. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher